Sorafenib for hepatocellular carcinoma before liver transplantation.
Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK.
Anya
A
Adair
Stephen J
SJ
Wigmore
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*
D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide